INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases,today announced that it will highlight key data associated with its lead candidate, INO-3107, at several upcoming conferences, including an opportunity to join other leading voices at the inaugural National HPV Conference. INOVIO will also discuss its novel DNA-encoded monoclonal antibody technology at a preconference workshop at the World Vaccine Congress.

https://mma.prnewswire.com/media/2310866/INOVIO_v1_Logo.jpg

National HPV Conference (Indianapolis, IN)April 15:

-- Oral presentation:DNA Immunotherapy (INO-3107) Results in a 72% Overall Response Rate in Year 1 for Treatment of Recurrent Respiratory Papillomatosis Caused by HPV-6 & 11

-- Panel:Recurrent Respiratory Papillomatosis: Lessons Learned, Clinical Advances and Patient Experiences - Moderated by Kim McClellan, RRP Foundation President

World Vaccine Congress (Washington, DC)April 21:

-- Oral presentation:A New Frontier in mAb Therapeutics: DNA-Encoded Monoclonal Antibodies (DMAb™) as Next Gen DNA Medicine

April 23:

-- Oral presentation:DNA Immunotherapeutics in the Treatment of Cancers and Virally-Mediated Diseases

Festival of Biologics (San Diego, CA)April 23:

-- Oral presentation:Advancing DNA Medicine: INO-3107 for Recurrent Respiratory Papillomatosis

Available abstracts will be shared on INOVIO's website following presentations.

About INOVIOINOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts

Media: Jennie Willson, (267) 429-8567, communications@inovio.comInvestors: Peter Vozzo - ICR Healthcare, (443) 213-0505,investor.relations@inovio.com

https://c212.net/c/img/favicon.png?sn=PH60556&sd=2025-04-09

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-present-at-upcoming-scientific-conferences-302424147.html

SOURCE INOVIO Pharmaceuticals, Inc.

https://rt.newswire.ca/rt.gif?NewsItemId=PH60556&Transmission_Id=202504090805PR_NEWS_USPR_____PH60556&DateId=20250409

COMTEX_464375804/1005/2025-04-09T08:05:28